(Also see "Are SPACs Good Or Bad For Biopharma?" - In Vivo, 15 February, 2021.)
SPACs Surge In 2020
Special Purpose Acquisition Companies Target Biopharma And Medtech: Infographic
Despite the COVID-19 chaos felt by many industries in 2020, biopharma IPOs recorded a banner year – including a marked rise in the use of special purpose acquisition companies (SPACs), also known as blank check companies.
